Pharmacological Management of Juvenile Rheumatoid Arthritis
- 1 June 1992
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 43 (6) , 849-863
- https://doi.org/10.2165/00003495-199243060-00005
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151. Clinical results and immunopharmacologic effects in an open study, including repeated administrationArthritis & Rheumatism, 1991
- Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritisThe Journal of Pediatrics, 1990
- Biliary elimination of low‐dose methotrexate in humansArthritis & Rheumatism, 1990
- CyclosporineNew England Journal of Medicine, 1989
- Advanced drug therapy for juvenile rheumatoid arthritisThe Journal of Pediatrics, 1989
- Liver histology in rheumatoid arthritis patients receiving long‐term methotrexate therapy. A Prospective Study with Baseline and Sequential Biopsy SamplesArthritis & Rheumatism, 1989
- The mechanisms of action of nonsteroidal antiinflammatory drugsArthritis & Rheumatism, 1989
- Penicillamine and Hydroxychloroquine in the Treatment of Severe Juvenile Rheumatoid ArthritisNew England Journal of Medicine, 1986
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- Auranofin in the treatment of juvenile rheumatoid arthritisThe Journal of Pediatrics, 1983